Jeffrey Robert Ajer is CCO & VP at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 43 open-market trades across 2 companies since 2012, most recently 2026-09-23.
CIK 0001557533
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 43 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL · 10b5-1 | 2024-05-02 | 2024-05-06 | $82.91 | $415K | -6.6% | -3.3% | -2.3% |
| BMRN | SELL · 10b5-1 | 2024-03-05 | 2024-03-07 | $87.07 | $348K | -0.7% | +1.6% | -7.3% |
| NKTR | SELL | 2023-09-18 | 2023-09-20 | $0.69 | $3K | -20.1% | -27.6% | -32.1% |
| BMRN | SELL · 10b5-1 | 2023-08-16 | 2023-08-17 | $90.00 | $450K | +5.8% | -0.8% | -2.5% |
| BMRN | SELL | 2023-01-25 | 2023-01-27 | $115.69 | $11.3M | -5.3% | -11.5% | -20.7% |
| BMRN | SELL | 2022-11-02 | 2022-11-04 | $86.12 | $258K | +4.1% | +25.6% | +36.8% |
| NKTR | SELL | 2022-09-23 | 2022-09-26 | $3.16 | $13K | +9.0% | +21.3% | -34.5% |
| BMRN | SELL | 2022-08-11 | 2022-08-12 | $95.62 | $287K | -2.4% | -5.2% | -12.5% |
| BMRN | SELL | 2022-05-26 | 2022-05-31 | $78.94 | $207K | -0.3% | +10.0% | +19.9% |
| BMRN | SELL | 2022-04-13 | 2022-04-14 | $82.47 | $195K | -2.0% | -5.6% | +7.6% |
| BMRN | SELL | 2022-03-29 | 2022-03-31 | $79.49 | $477K | +7.0% | +7.9% | +8.7% |
| BMRN | SELL | 2022-03-22 | 2022-03-24 | $81.67 | $1.2M | -1.4% | +1.6% | +0.9% |
| BMRN | SELL | 2021-10-26 | 2021-10-28 | $73.60 | $403K | +6.4% | +12.3% | +7.6% |
| NKTR | SELL | 2021-09-22 | 2021-09-24 | $17.78 | $130K | -13.1% | -13.1% | -15.5% |
| BMRN | SELL | 2021-04-08 | 2021-04-09 | $78.81 | $242K | +3.6% | -0.2% | +8.3% |
| BMRN | SELL | 2021-03-30 | 2021-04-01 | $74.79 | $247K | +0.2% | +0.8% | +6.9% |
| BMRN | SELL | 2021-03-24 | 2021-03-26 | $76.30 | $180K | +4.2% | +8.1% | +11.6% |
| BMRN | SELL | 2021-03-18 | 2021-03-19 | $77.99 | $204K | -3.4% | +1.8% | +6.1% |
| BMRN | SELL | 2020-10-14 | 2020-10-15 | $79.91 | $339K | -2.2% | -1.0% | +5.2% |
| NKTR | SELL | 2020-09-28 | 2020-09-30 | $17.25 | $112K | +4.2% | -4.3% | +10.2% |
| NKTR | SELL · 10b5-1 | 2020-09-21 | 2020-09-21 | $19.74 | $44K | -14.1% | -14.6% | -4.2% |
| BMRN | SELL | 2020-06-19 | 2020-06-23 | $124.00 | $1.9M | +5.3% | +2.6% | -36.3% |
| BMRN | SELL | 2020-04-08 | 2020-04-09 | $79.98 | $385K | +16.3% | +21.3% | +61.9% |
| BMRN | SELL | 2020-04-01 | 2020-04-02 | $82.00 | $126K | -3.2% | +6.2% | +47.9% |
| BMRN | SELL | 2020-03-24 | 2020-03-26 | $76.18 | $557K | -0.9% | +21.6% | +49.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.